ICU Medical Inc (ICUI) Stock Forecast & Price Target
ICU Medical Inc · NASDAQ
$167.48+1.19 (+0.72%)
15-min delayed · Sep 4, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 4 firms covering ICU Medical Inc, 4 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets are tightly clustered, $182.00 to $200.00, so the covering firms are broadly aligned. The average target of $191.00 sits 14% above the current $167.48. The rating mix has stayed broadly stable, with Buy-side ratings easing from 5 to 4 over recent months. On the fundamentals, the Street sees consensus EPS building from about $2.23 next quarter toward $9.65 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS4 ratings
Strong Buy
Strong Buy00%
Buy4100%
Hold00%
Sell00%
Strong Sell00%
Based on 4 analysts giving stock ratings to ICU Medical Inc.
As of Sep, 4 of 4 firms rate ICUI a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
ICUI EPS & revenue forecast
EPS · NEXT QUARTER
$2.23
Range $2.16 – $2.29 · 7 analysts · +17% YoY
Next period, 7 analysts expect ICU Medical Inc to earn $2.23 a share (range $2.16 – $2.29), versus $1.91 a year earlier. Full-year consensus is $8.75, growing to $9.65 the year after.
REVENUE · NEXT QUARTER
$561.6M
Range $554.8M – $569.4M · 7 analysts · +5% YoY
Revenue is expected to reach $561.6M (range $554.8M – $569.4M), +4.8% year-over-year. Full-year consensus is $2.2B, rising to $2.3B next year.
Top analysts covering ICU Medical Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ICUI.
#1
JB
Jayson Bedford
Raymond James · Rank #196
Buy
$180.00+7.5% to target
Overall win rate
42%
+ Follow
#2
Mike Matson
Needham · Rank #210
Buy
$187.00+11.7% to target
Overall win rate
34%
+ Follow
#3
Jason Bednar
Piper Sandler · Rank #276
Buy
$195.00+16.4% to target
Overall win rate
35%
+ Follow
#4
Tim Rezvan
Keybanc · Rank #282
Buy
$191.00+14.0% to target
Overall win rate
34%
+ Follow
#5
Brett Fishbin
KeyBanc
Buy
$182.00+8.7% to target
Coverage
—
+ Follow
ICUI stock forecast FAQ
What is ICUI's average 12-month price target?+
The 4 analysts with a live target average $191.00 for ICU Medical Inc over the next 12 months, ranging from a $200.00 high to a $182.00 low.
Is ICUI stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 4 analyst ratings, 4 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for ICUI?+
The Street-high target is $200.00 (BTIG), and the Street-low is $182.00 (Keybanc). The average of all 4 active targets is $191.00.
How many Wall Street analysts cover ICUI?+
4 analysts have an active rating on ICU Medical Inc, and 4 firms carry a live 12-month price target.
Who is the most accurate analyst covering ICUI?+
Among analysts who currently cover ICUI, Jayson Bedford of Raymond James has the strongest overall Quantellect track record (Rank #196). Their current call is Buy with a $180.00 target.
What is ICU Medical Inc's projected EPS for next quarter?+
The consensus estimate is $2.23 per share (range $2.16 – $2.29) across 7 analysts. Full-year EPS is projected at $8.75, rising to $9.65 the following year.
How much revenue is ICU Medical Inc expected to report next quarter?+
Consensus revenue is $561.6M (range $554.8M – $569.4M). Full-year revenue is projected at $2.2B, growing to $2.3B next year.
Have analysts been upgrading or downgrading ICUI lately?+
As of Sep, 4 of 4 firms rate ICUI a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ICUI calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
